Article Text

other Versions

PDF
Review
Cilostazol: an antiplatelet agent for the neurointerventionist?
  1. P Bhogal1,
  2. P A Brouwer1,
  3. H L D Makalanda2
  1. 1Department of Neuroradiology, The Karolinska University Hospital, Stockholm, Sweden
  2. 2Department of Interventional Neuroradiology, The Royal London Hospital, London, UK
  1. Correspondence to Dr P Bhogal, Department of Neuroradiology, The Karolinska University Hospital, Stockholm 17176, Sweden; bhogalweb{at}aol.com

Abstract

Antiplatelet agents are essential for the successful management of patients undergoing a variety of neurointerventional procedures. The most commonly used anti-platelet agents are aspirin, clopidogrel and prasugrel. However, there exist an alternative class of anti-platelet agent that may prove useful for neurointerventionists. In particular a drug called cilostazol may have numerous added advantages above and beyond its antiplatelet effect that may be valuable for our patients. In this short review we aim to highlight some of these potential advantages.

  • Platelets
  • Atherosclerosis
  • Intervention
  • Plaque
  • Subarachnoid

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.